Companies

Lexeo Therapeutics, Inc. (LXEO) SEC filings

CIK 0001907108 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)654000
Net income (USD)-98.3 M-66.4 M-59.3 M
Diluted EPS (USD/shares)-1.86-12.4-36.36

Latest filings

FiledFormDescriptionPeriod
2026-10-13SCHEDULE 13GSCHEDULE 13G
2026-09-298-K8-K items 2.01,3.02,9.012026-09-29
2026-09-28442026-09-24
2026-09-28442026-09-24
2026-09-28442026-09-24
2026-09-28442026-09-24
2026-09-228-K8-K items 1.01,8.01,9.012026-09-16
2026-08-19442026-08-18
2026-08-19442026-08-18
2026-08-19442026-08-18
2026-08-18144144
2026-08-18144144
2026-08-18144144
2026-08-14SCHEDULE 13GSCHEDULE 13G
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-1210-Q10-Q2026-06-30
2026-08-128-K8-K items 2.02,8.01,9.012026-08-12
2026-08-07SCHEDULE 13GSCHEDULE 13G
2026-07-01442026-06-29
2026-07-01442026-06-29
2026-07-01442026-06-29
2026-07-01442026-06-29
2026-07-01144144

Forms on file (last 1,000): 4 98, 144 42, 8-K 38, SCHEDULE 13G/A 30, 3 21, SCHEDULE 13G 15, 424B3 15, 10-Q 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=LXEO (0.002 USD), /gw/filings/filings?ticker=LXEO&form=8-K, /gw/filings/facts?ticker=LXEO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange